Skip to main content
. 1999 Dec;37(12):4039–4041. doi: 10.1128/jcm.37.12.4039-4041.1999

TABLE 1.

Clinical data from 18 patients with pneumococcal conjunctivitisb

Samplea Type Source Diagnosis or diagnoses Date of isolation (mo/day/yr) Age
1 AA Eye Conjunctivitis 5/17/95 14 yr
2 AA Eye Conjunctivitis 6/5/95 13 mo
3 AA Eye Conjunctivitis, otitis media 3/2/95 17 mo
4 AA Eye Conjunctivitis 3/17/95 29 mo
5 AA Eye Conjunctivitis 5/9/95 8 yr
6 AA Eye Conjunctivitis 3/20/95 23 yr
7 AA Eye Conjunctivitis 4/27/95 4 yr, 10 mo
8 AA Eye Conjunctivitis 3/3/95 16 mo
9 AA Eye Conjunctivitis, rhinitis 3/11/95 2 mo
10 AA Eye Conjunctivitis, URI 5/1/95 6 mo
11 3 Eye Conjunctivitis 5/1/95 2 mo
12 6B Eye Conjunctivitis 2/21/95 30 mo
13 8 Eye Conjunctivitis, otitis media 6/23/95 21 mo
14 11A Eye Conjunctivitis, pharyngitis, rhinitis 2/23/95 31 mo
15 23F Eye Conjunctivitis 2/28/95 19 mo
16 6B Eye Conjunctivitis, URI 3/6/95 3 mo
17 6B Eye Conjunctivitis 4/6/95 7 yr
18 I Eye Conjunctivitis, URI, thrush 5/10/95 3 mo
Illinois AA Eye Epidemic conjunctivitis ?/?/96
19 3 Throat Sinusitis, pharyngitis 6/12/95 25 yr
20 9V Abdominal drainage Abdominal cellulitis 4/3/95 28 yr
21 19F Blood and CSF Sepsis, meningitis 3/22/95 2 mo
22 23F Blood Septic shock (fatal) 3/10/95 52 yr
23 9V Sputum Burn patient 2/27/95 46 yr
a

The Illinois sample represents the genotype identified in cases of epidemic conjunctivitis among military recruits (1). This sample and samples 19 through 23 are included for comparison. 

b

AA, an autoagglutinating strain; CSF, cerebrospinal fluid; URI, upper respiratory tract infection. 

HHS Vulnerability Disclosure